Abstract |
The immunogenicity and efficacy of influenza vaccination are markedly lower in the elderly. Granzyme B (GrzB), quantified in fresh cell lysates, has been suggested to be a marker of cytotoxic T lymphocyte (CTL) response and a predictor of influenza illness among vaccinated older individuals. We have developed an influenza-specific GrzB ELISPOT assay using cryopreserved PBMCs. This method was tested on 106 healthy older subjects (ages 50-74) at baseline (Day 0) and three additional time points post-vaccination (Day 3, Day 28, Day 75) with influenza A/H1N1-containing vaccine. No significant difference was seen in GrzB response between any of the time points, although influenza-specific GrzB response appears to be elevated at all post-vaccination time points. There was no correlation between GrzB response and hemagglutination inhibition (HAI) titers, indicating no relationship between the cytolytic activity and humoral antibody levels in this cohort. Additionally, a significant negative correlation between GrzB response and age was observed. These results reveal a reduction in influenza-specific GrzB response as one ages. In conclusion, we have developed and optimized an influenza-specific ELISPOT assay for use with frozen cells to quantify the CTL-specific serine protease GrzB, as a measure of cellular immunity after influenza vaccination.
|
Authors | Hannah M Salk, Iana H Haralambieva, Inna G Ovsyannikova, Krista M Goergen, Gregory A Poland |
Journal | Journal of immunological methods
(J Immunol Methods)
Vol. 398-399
Pg. 44-50
(Dec 15 2013)
ISSN: 1872-7905 [Electronic] Netherlands |
PMID | 24055591
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | © 2013. |
Chemical References |
- Influenza Vaccines
- GZMB protein, human
- Granzymes
|
Topics |
- Age Factors
- Aged
- Enzyme-Linked Immunospot Assay
(methods)
- Female
- Granzymes
(blood, immunology)
- Humans
- Immunity, Cellular
(drug effects)
- Influenza A virus
(immunology, metabolism)
- Influenza Vaccines
(administration & dosage, immunology)
- Influenza, Human
- Male
- Middle Aged
|